| whytestocks: $CRSP News Article - 2 Growth Stocks That Could Keep Growing for Decades |
| @ |
04/21/2023 4:00:49 PM |
| Vertex and CRISPR Therapeutics Announce Licensing Agreement to |
| @Harper |
04/20/2023 12:52:56 AM |
| $CRSP - Interesting Video from Dylan Jovine |
| @gjones2764 |
04/19/2023 11:58:21 PM |
| Based on the data for CTX110 (a first-gen |
| @RichardPClemenceau |
04/19/2023 7:25:05 PM |
| Another bio with endless research in crowded field, |
| @rtaymor |
04/19/2023 4:10:47 PM |
| whytestocks: $CRSP News Article - Why CRISPR Therapeutics Stock Is Marching Higher Today |
| @ |
04/17/2023 8:25:51 PM |
| whytestocks: $CRSP News Article - Why Shares of Editas Medicine Rose Monday |
| @ |
04/17/2023 7:05:49 PM |
| Slide deck http://ir.crisprtx.com/static-files/ce2efeb9-3319-4504-8430-13058b305 |
| @peterpiper |
04/17/2023 6:22:34 PM |
| whytestocks: $CRSP News Article - CRISPR Therapeutics to Participate in Needham's 22nd Annual Healthcare Conferen |
| @ |
04/13/2023 8:05:51 PM |
| The therapies for SCD could be cost effective |
| @tomsey |
04/13/2023 7:58:14 PM |
| Investment analysts at Cantor Fitzgerald started coverage on |
| @MDhaimesh |
04/13/2023 3:10:22 PM |
| Both are now recruiting. For the CTX131 trial |
| @johnchief |
04/10/2023 9:50:59 PM |
| An historical milestone https://finance.yahoo.com/news/vertex-crispr-therapeutic |
| @mikets |
04/03/2023 6:49:18 PM |
| VRTX has signed a licensing deal to accelerate |
| @cruzak |
03/27/2023 8:34:05 PM |
| $CRSP - From: Simply Wall St |
| @jimmajr |
03/17/2023 2:02:21 PM |
| This will be an oral presentation (of preclinical |
| @AABB |
03/15/2023 9:21:42 PM |
| CRISPR Therapeutics to Present at the American Association |
| @fuckmwn |
03/15/2023 5:04:17 AM |
| CTX112 and CTX131: Next-generation CRISPR/Cas9-engineered allogeneic (allo) CAR |
| @raysodyssey |
03/15/2023 1:48:00 AM |
| $CRSP current short interest is approx 15%. With |
| @testtest |
01/18/2023 3:10:48 PM |
| They are also working on iPSC-derived CAR-NK cells |
| @JimmyOneTime |
01/13/2023 12:20:38 AM |
| From this: ''Ultimately, Kulkarni says, CRISPR Therapeutics aims |
| @gduhamel |
01/13/2023 12:10:38 AM |
| Scalped an easy 15% here in no time. |
| @JOHNB214 |
01/05/2023 6:58:12 PM |
| YES! In my 401k now at $41 |
| @GO2022 |
01/05/2023 1:43:13 AM |
| Good Entry for Long |
| @gduhamel |
12/29/2022 2:07:05 PM |
| I have patience and don't mind the gyrations |
| @Mohitpatil |
12/28/2022 2:03:10 PM |
| I think that people are not truly seeing |
| @Drharoonafridi |
12/28/2022 12:43:40 AM |
| Motley Fool article brings gene editing into focus: |
| @Mrcream456 |
12/27/2022 7:11:57 PM |
| $CRSP sports a 16+% short interest position right |
| @mookietheastro |
12/19/2022 8:50:30 PM |
| Neogene plans to do the same https://www.fiercebiotech.com/biotech/astrazeneca-f |
| @HandyManz |
12/14/2022 10:13:35 PM |
| PRs https://finance.yahoo.com/news/vertex-crispr-therapeutics-present-american-1 |
| @MickGO |
12/14/2022 10:11:45 PM |
| whytestocks: $CRSP News Article - CRISPR Therapeutics Provides Update on Its Ongoing Phase 1 CARBON(TM) Trial of |
| @ |
12/12/2022 6:40:47 PM |
| https://www.nature.com/articles/d41586-022-03676-7 |
| @rgordon908 |
11/11/2022 10:35:53 PM |
| ASH abstracts |
| @adgwealth |
11/03/2022 5:38:34 PM |
| SITC titles |
| @carolina |
10/05/2022 7:35:27 PM |
| whytestocks: $CRSP News Article - CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) |
| @ |
09/28/2022 7:46:05 PM |
| whytestocks: $CRSP News Article - Why Is Crispr Therapeutics (CRSP) Stock Up Today? |
| @ |
09/27/2022 3:05:55 PM |
| $CRSP continues to expect to move multiple programs |
| @Oilguy |
08/29/2022 7:14:55 PM |
| https://www.the-scientist.com/news-opinion/first-person-dosed-in-novel-gene-edit |
| @amygdala_88 |
07/15/2022 10:29:44 PM |
| whytestocks: $CRSP News Article - The Best 3 Stocks in Cathie Wood's Ark ETF Have 1 Thing in Common |
| @ |
07/13/2022 6:15:54 PM |
| Slides http://ir.crisprtx.com/static-files/5c256eb5-4982-4e47-b463-79eff954e622 |
| @KevGardner |
06/21/2022 10:30:20 PM |
| whytestocks: $CRSP News Article - 3 Bargain Stocks You Can Buy Today and Hold Forever |
| @ |
06/17/2022 12:45:58 PM |
| Link to webcast https://media.rampard.com/WebcastingAppv5/Events/Registration/re |
| @Fefebull999 |
06/08/2022 7:35:45 PM |
| whytestocks: $CRSP News Article - 7 Oversold Stocks to Buy Right Now |
| @ |
06/08/2022 12:55:54 PM |
| Too bad $GNCA NPT with CAR knock in |
| @bostonmjf |
06/07/2022 12:51:45 PM |
| They start with healthy donor fibroblasts, reprogram to |
| @grrlonfire |
06/06/2022 10:59:02 PM |
| 500 clones from different editing sequences? What gets |
| @cottle |
06/06/2022 10:05:18 PM |
| Either they make all the edits at the |
| @AliciaNg |
06/05/2022 4:51:43 PM |
| That is a lot of man made mutations. |
| @Jdbaymon |
06/05/2022 2:39:47 AM |
| They haven't publicly disclosed anything (yet), but the |
| @Dishank111 |
06/04/2022 7:52:14 PM |
| How many gene edit/inserts will be required in |
| @Billychrist21 |
06/04/2022 2:29:41 PM |
| Ultimately, the company aims to move to iPSC-derived |
| @jlatner |
06/04/2022 1:02:50 AM |
| I let 5% of my shares go today |
| @global_mkts |
06/02/2022 5:15:51 PM |
| The company will host an innovation day focused |
| @RightOn |
06/01/2022 1:47:20 AM |
| I added $CRSP as a new position at |
| @Carolng |
05/16/2022 1:25:06 PM |
| Speaking of anti-CD70 CAR-T's https://www.sciencedirect.com/science/article/abs |
| @edd |
05/12/2022 10:07:16 PM |
| EHA PR https://www.globenewswire.com/news-release/2022/05/12/2442178/0/en/CRISPR |
| @Joewharton2 |
05/12/2022 6:20:20 PM |
| As for edits, knockouts (in addition to CD70) |
| @Sassybitch |
04/17/2022 10:07:32 PM |
| They are also working with $NKTX on three |
| @Lus11 |
04/17/2022 10:05:09 PM |
| The company hopes to have an R&D Day |
| @Bibbybkw |
04/17/2022 10:02:17 PM |
| My day order to buy $CRSP at $65.40 |
| @janelangley |
04/06/2022 5:29:15 PM |
| whytestocks: $CRSP News Article - Is CRISPR Therapeutics Stock a Buy Now? |
| @ |
03/16/2022 4:06:02 PM |
| whytestocks: $CRSP News Article - Vertex and CRISPR Therapeutics Present New Data in 22 Patients With Greater Tha |
| @ |
06/11/2021 8:45:49 PM |
| whytestocks: $CRSP News Article - Vertex Pharmaceuticals and CRISPR Therapeutics Amend Collaboration for Developm |
| @ |
04/20/2021 4:19:45 PM |
| whytestocks: $CRSP News Article - CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing |
| @ |
12/14/2020 5:25:49 PM |
| whytestocks: $CRSP News Article - CRISPR and Vertex Release Additional Data for Blood Disease Treatment |
| @ |
11/04/2020 7:25:48 PM |
| whytestocks: $CRSP News Article - CRISPR Therapeutics Congratulates Co-Founder Emmanuelle Charpentier on Receivin |
| @ |
10/07/2020 3:10:52 PM |
| whytestocks: $CRSP must see |
| @ |
12/25/2019 4:25:44 PM |
| whytestocks: $CRSP News Article - Is Amarin's Fish Oil Pill on Track to Become a Blockbuster? |
| @ |
11/22/2019 7:00:43 PM |
| whytestocks: $CRSP News Article - Here's Why CRISPR Stocks Are Soaring Today |
| @ |
11/19/2019 8:45:42 PM |
| whytestocks: $CRSP News Article - CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From |
| @ |
11/19/2019 1:55:42 PM |
| whytestocks: $CRSP News Article - CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Fin |
| @ |
10/28/2019 2:50:51 PM |
| whytestocks: $CRSP News Article - 3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year |
| @ |
10/08/2019 12:55:41 PM |
| whytestocks: $CRSP News Article - Should Investors Buy or Sell Sangamo Therapeutics Right Now? |
| @ |
10/08/2019 12:50:42 PM |
| znewcar1: 25.20% v4,106,711 c39.65 f52,111,507 Into the 30dma big vol |
| @raj0654 |
02/25/2019 9:42:18 PM |